New Hidradenitis Suppurativa Care Guidelines

New joint standards help millions of Americans with the painful skin condition get a more accurate diagnosis.

Updated on Oct. 21, 2026 in Cancer

Gouache-painted illustration of a clean abstract sculptural form, representing clinical precision and standardized medical care.
The American Academy of Dermatology and the Hidradenitis Suppurativa Foundation have released new joint clinical guidelines to standardize care for patients. AI Illustration. Upload story photo >

Live Poll

Do you trust that new medical guidelines will effectively improve care for chronic skin conditions?

The American Academy of Dermatology and the Hidradenitis Suppurativa Foundation have released new joint clinical guidelines for managing hidradenitis suppurativa (HS). This chronic condition, which affects over 3 million people in the United States, involves painful lumps developing deep under the skin.

Why it matters

Early diagnosis remains essential for patients as HS is frequently misidentified as acne or common infections. These updated guidelines aim to standardize care and help clinicians identify the condition alongside potential psychiatric or medical comorbidities.

These clinical practice guidelines represent an official consensus from the American Academy of Dermatology and the Hidradenitis Suppurativa Foundation. While the prevalence affects 3 million individuals, the precise impact of standardized screening protocols on long-term disease outcomes remains under study.

The players

American Academy of Dermatology

A professional society representing board-certified dermatologists that establishes evidence-based clinical standards for skin care.

Hidradenitis Suppurativa Foundation

An organization dedicated to supporting individuals affected by hidradenitis suppurativa through research and education.

The details

Hidradenitis suppurativa manifests as painful lumps, typically appearing in skin-fold areas such as the armpits, inner thighs, and groin. Board-certified dermatologists lead the management of this condition by conducting screenings for associated medical and psychiatric illnesses that often accompany the skin disease. By establishing these formal guidelines, the organizations seek to improve diagnostic accuracy and prevent the common confusion between HS and routine acne or infections.

Timeline

  1. October 20, 2026: The joint guidelines for hidradenitis suppurativa care were published.

Health Landscape

This release updates the American Academy of Dermatology's clinical guideline library by providing the first joint standard for managing this chronic condition. It reflects a broader shift toward multidisciplinary care that addresses both the dermatological symptoms and comorbid health conditions.

If you experience recurring painful lumps in skin folds, discuss these specific screening guidelines with a board-certified dermatologist. Because HS is often confused with acne, obtaining a formal diagnosis is the essential first step toward accessing appropriate clinical management.

The takeaway

Hidradenitis suppurativa is a specific, chronic condition that requires specialized dermatological care to distinguish it from common skin infections. If you suspect you have HS, prioritize a consultation with a dermatologist who can screen for the condition and its associated health implications.

Further reading

For more information on skin-related conditions, visit the Cancer section.

Live Poll

Do you trust that new medical guidelines will effectively improve care for chronic skin conditions?